Chester County News and Community Website
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
MALVERN, PA — Meridian Corporation (Nasdaq: MRBK), a prominent player in the banking industry, recently unveiled its financial results for the final quarter of 2023. Demonstrating significant growth, the company’s …
Meridian Corporation’s Latest Earnings: A Symphony of Growth offset by Challenges, with a Dividend Encore Read More
MALVERN, PA — Cantaloupe, Inc. (Nasdaq: CTLP), a leading player in the technology sector, has announced it will host a webcast to discuss the company’s financial results for the second …
Cantaloupe Inc. To Shed Light on Q2 2024 Earnings in Upcoming Webcast Read More
RADNOR, PA — NRx Pharmaceuticals, Inc., a biopharmaceutical company listed on Nasdaq, has announced that it has been granted permission by The Nasdaq Hearings Panel to transfer its listing to …
NRx Pharmaceuticals Granted Transfer to Nasdaq Capital Market Amid Key Drug Development Milestones Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a Pennsylvania-based leader in the medical technology industry, recently announced that it has granted restricted stock units (RSUs) covering 5,500 shares of …
TELA Bio’s Strategic Move: Offering Restricted Stock Units to New Hires Read More
MALVERN, PA — In a strategic move aimed at expanding its global footprint, Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies, has welcomed …
Ocugen Bolsters Business Advisory Board with Former Pfizer Executive, Eyes Global Expansion Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a biopharmaceutical company specializing in dermatological treatments, has announced significant changes to its leadership and an impending strategic review of its business …
Aclaris Therapeutics Announces Leadership Shake-up and Strategic Review, Investors Watch Closely Read More WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has released promising top-line results from its Phase 2b study of ATI-1777, a topical “soft” JAK 1/3 inhibitor developed for treating mild …
Aclaris Therapeutics Announces Promising Phase 2b Results for ATI-1777, Boosting Investor Confidence Read More
EXTON, PA — Immunome, Inc. (Nasdaq: IMNM), a Pennsylvania-based biopharmaceutical company, announced the recent appointment of Carol A. Schafer to its Board of Directors, marking another strategic move for the …
Immunome Appoints Experienced Investment Banker, Carol A. Schafer, to Board of Directors Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a leader in dermatology therapeutics, announced a significant development in its ongoing research for innovative skin cancer treatments. The company confirmed …
Verrica Pharmaceuticals Achieves Milestone in Phase 2 Trial of Groundbreaking Skin Cancer Therapy Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced that it received the minutes from its recent Type C meeting with the U.S. Food and Drug Administration (FDA). …
Verrica Pharmaceuticals Gains FDA Alignment for YCANTH’s Phase 3 Clinical Development Plan Read More